NCT00491894View on ClinicalTrials.gov

Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions

PHASE3CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions
Cerebral PalsyNeurological ConditionsMental RetardationSialorrhea
Interventions
DRUG

Oral Glycopyrrolate Liquid

Study medication is administered three times a day at 7-8 AM, 1-2 PM, and 7-8 PM by the parent/caregiver

Trial Locations (7)

11360

St. Mary's for Children, Bayside

30342

Child Neurology Associates, PC, Atlanta

44255

Hattie Larltham Center for Children with Disabilities, Mantua

44308

Akron's Childrens, Akron

73008

The Children's Center, Bethany

78258

Alamo City Clinical Research, San Antonio

80214

Rocky Mountain Pediatrics, Lakewood

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY

NCT00491894 - Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions | Biotech Hunter | Biotech Hunter